Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2023		Dec. 31, 2022
Assets
Cash and cash equivalents		$ 37,472		$ 33,172
Federal funds sold		90,170		72,426
Investment securities		53,175		48,492
Equity investments		10,542		10,293
Loans		2,203,038		1,916,953
Allowance for loan losses		(79,133)	[1]	(63,845)	[2]
Net loans receivable		2,123,905		1,853,108
Goodwill		150,803		150,803
Intangible assets, net		20,952		22,035
Loan collateral in process of foreclosure	[3]	15,923		21,819
Accrued interest receivable		13,593		12,613
Property, equipment, and right-of-use lease asset, net		13,278		13,168
Income tax receivable		0		2,095
Other assets		28,814		19,855
Total assets		2,558,627		2,259,879
Liabilities
Deposits	[4]	1,855,096		1,607,110
Long-term debt	[5]	218,137		214,320
Short-term borrowings		18,489		5,000
Deferred tax liabilities, net		23,131		26,753
Operating lease liabilities		7,075		8,408
Accrued interest payable		4,624		4,790
Income tax payable		2,866		0
Accounts payable and accrued expenses	[6]	31,947		22,974
Total liabilities		2,161,365		1,889,355
Commitments and contingencies
Stockholders’ equity
Preferred stock (1,000,000 shares of $0.01 par value stock authorized-none outstanding)		0		0
Common stock (50,000,000 shares of $0.01 par value stock authorized - 28,965,885 shares at September 30, 2023 and 28,663,827 shares at December 31, 2022 issued)		290		287
Additional paid in capital		286,782		283,663
Treasury stock (5,602,154 shares at September 30, 2023 and December 31, 2022)		(45,538)		(45,538)
Accumulated other comprehensive loss		(4,960)		(3,349)
Retained earnings		91,900		66,673
Total stockholders’ equity		328,474		301,736
Non-controlling interest in consolidated subsidiaries		68,788		68,788
Total equity		397,262		370,524
Total liabilities and equity		$ 2,558,627		$ 2,259,879
Number of shares outstanding		23,363,731		23,061,673
Book value per share		$ 14.06		$ 13.08

[1] As of September 30, 2023 and September 30, 2022, there were no allowance for credit losses and net charge-offs related to the strategic partnership loans.

[2] Represents allowance prior to the adoption of ASU 2016-13.

[3] Includes financed sales of this collateral to third parties that are reported separately from the loan portfolio, of $6.2 million as of September 30, 2023 and $7.5 million as of December 31, 2022.

[4] Includes $4.1 million and $3.8 million of deferred financing costs as of September 30, 2023 and December 31, 2022. Refer to Note 5 for more details.

[5] Includes $4.1 million and $3.2 million of deferred financing costs as of September 30, 2023 and December 31, 2022. Refer to Note 5 for more details.

[6] Includes the short-term portion of lease liabilities of $2.2 million as of both September 30, 2023 and December 31, 2022. Refer to Note 6 for more details.